In a systematic review of eight studies involving 6,648 patients, robotic pancreaticoduodenectomy (RPD) demonstrated significant advantages over laparoscopic pancreaticoduodenectomy (LPD) for malignant lesions. Key findings included a reduced length of hospitalization (mean difference of -0.94 days), lower conversion rates (odds ratio of 0.20), and a higher number of harvested lymph nodes (mean difference of 1.02). Overall morbidity was also lower in the RPD group (odds ratio of 0.50), although some outcomes showed no significant differences.
Review by Kossenas K, Kouzeiha R, Moutzouri O and Georgopoulos F in J Robot Surg
© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.